Buy White Crystalline Powder Treat Breast Cancer Trilostane 13647-35-3 , White Crystalline Powder Treat Breast Cancer Trilostane 13647-35-3 Suppliers, Manufacturers, Traders










You Are In: Home / Chemical Categories / White Crystalline Powder Treat Breast Cancer Trilostane 13647-35-3 Suppliers

White Crystalline Powder Treat Breast Cancer Trilostane 13647-35-3 Suppliers

white crystalline powder treat breast cancer trilostane 13647-35-3

Welcome to inquiry!

Email: tony@kafenbio.com

WhatsApp: +8618002259573

Skype: tony_14616

www.pharmhormone.com

 
White Crystalline Powder Treat Breast Cancer Trilostane 13647-35-3
 
Trilostane Basic Info.
 
Product Name: Trilostane
Synonym: Trilostane;Vetoryl;Modrenal
CAS: 13647-35-3
Molecular Formula: C20H27NO3
Molecular Weight: 329.43
Einecs No.: 237-133-0
Assay: 99%
Melting point: 264 °C
Storage temp.: -20°C Freezer
Storage: Shading, confined preservation
Grade: Pharmaceutical Grade
Appearance: White crystalline powder
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;Inhibitor;FULVICIN.
Usage: 
(1)Trilostane can inhibit cortical hormone in the process of synthesis of 3 beta dehydrogenase, make the cortisol, aldosterone synthesis decreased;
(2)Clinically used in the treatment of Cushing syndrome (hypercortisolism) and primary aldosteronism. 
(3)Trilostane also had significantly effect to decreased serum testosterone level.
 
Trilostane Description:
 
Trilostane is used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible. Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland.
Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids.
 
Side effect:Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.
 
Trilostane Application:
 
Trilostane can suppress cortical hormone synthesis process of 3 beta dehydrogenase, make cortisol, aldosterone synthesis reduce, clinical used in the treatment of Cushing syndrome(cortisol increase disease) and primary aldosteronism,the effect is not good than testosterone metyrapone. This product has significantly reduced blood testosterone level role, may relevant to its inhibit synthetic.
 
CAS Number:13647-35-3
white crystalline powder treat breast cancer trilostane 13647-35-3

Welcome to inquiry!

Email: tony@kafenbio.com

WhatsApp: +8618002259573

Skype: tony_14616

www.pharmhormone.com

 
White Crystalline Powder Treat Breast Cancer Trilostane 13647-35-3
 
Trilostane Basic Info.
 
Product Name: Trilostane
Synonym: Trilostane;Vetoryl;Modrenal
CAS: 13647-35-3
Molecular Formula: C20H27NO3
Molecular Weight: 329.43
Einecs No.: 237-133-0
Assay: 99%
Melting point: 264 °C
Storage temp.: -20°C Freezer
Storage: Shading, confined preservation
Grade: Pharmaceutical Grade
Appearance: White crystalline powder
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;Inhibitor;FULVICIN.
Usage: 
(1)Trilostane can inhibit cortical hormone in the process of synthesis of 3 beta dehydrogenase, make the cortisol, aldosterone synthesis decreased;
(2)Clinically used in the treatment of Cushing syndrome (hypercortisolism) and primary aldosteronism. 
(3)Trilostane also had significantly effect to decreased serum testosterone level.
 
Trilostane Description:
 
Trilostane is used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible. Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland.
Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids.
 
Side effect:Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.
 
Trilostane Application:
 
Trilostane can suppress cortical hormone synthesis process of 3 beta dehydrogenase, make cortisol, aldosterone synthesis reduce, clinical used in the treatment of Cushing syndrome(cortisol increase disease) and primary aldosteronism,the effect is not good than testosterone metyrapone. This product has significantly reduced blood testosterone level role, may relevant to its inhibit synthetic.
 
CAS Number:13647-35-3

Guangzhou Kafen Biotech Co.,Ltd.

No.128,Hanxing East Rd, Zhongcun, Panyu District, Guangzhou, Guangdong, China, guangzhou, china

china china

White White
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X